Earnings Feed
Start Free
LIGAND PHARMACEUTICALS INC·4

Feb 13, 2:17 PM ET

Kazmi Syed 4

4 · LIGAND PHARMACEUTICALS INC · Filed Feb 13, 2012

Insider Transaction Report

Form 4
Period: 2012-02-09
LIGAND PHARMACEUTICALS INCLGNDD
Kazmi Syed
VP, Bus. Dev. & Strategic Plan
Transactions
  • Award

    Common Stock

    2012-02-09+4,000→ 18,230 total
  • Award

    Incentive Stock Option (right to buy)

    2012-02-09$14.47/sh+16,866$244,051→ 16,866 total
    Exercise: $14.47Exp: 2022-02-09→ Common Stock (16,866 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2012-02-09$14.47/sh+8,134$117,699→ 8,134 total
    Exercise: $14.47Exp: 2022-02-09→ Common Stock (8,134 underlying)
Footnotes (1)
  • [F1]Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT